240 related articles for article (PubMed ID: 29158023)
1. Statin has more protective effects in AMI patients with higher plasma BNP or NT-proBNP level, but not with lower left ventricular ejection fraction.
Cho J; Park IB; Lee K; Ahn TH; Park WB; Kim JH; Ahn Y; Jeong MH; Lee DH;
J Cardiol; 2018 Apr; 71(4):375-381. PubMed ID: 29158023
[TBL] [Abstract][Full Text] [Related]
2. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide.
Omland T; Aakvaag A; Bonarjee VV; Caidahl K; Lie RT; Nilsen DW; Sundsfjord JA; Dickstein K
Circulation; 1996 Jun; 93(11):1963-9. PubMed ID: 8640969
[TBL] [Abstract][Full Text] [Related]
3. Effect of metoprolol tartrate tablets and recombinant human B-type natriuretic peptide on the sudden cardiac death and malignant arrhythmias in patients with acute myocardial infarction and heart failure.
Liu C; Yao L; Zhang L; Lin Y
Pak J Pharm Sci; 2021 Nov; 34(6(Special)):2473-2478. PubMed ID: 35039262
[TBL] [Abstract][Full Text] [Related]
4. Effects of Statin Therapy on Clinical Outcomes of Survivors of Acute Myocardial Infarction with Severe Systolic Heart Failure.
Woo JS; Hwang SJ; Kim HS; Kim JB; Kim WS; Kim KS; Jeong MH; Kim W;
PLoS One; 2015; 10(12):e0144602. PubMed ID: 26658751
[TBL] [Abstract][Full Text] [Related]
5. Atorvastatin therapy is associated with reduced levels of N-terminal prohormone brain natriuretic peptide and improved cardiac function in patients with heart failure.
Stypmann J; Schubert A; Welp H; Schulte H; Assmann G; Breithardt G; Nofer JR
Clin Cardiol; 2008 Oct; 31(10):478-81. PubMed ID: 18855352
[TBL] [Abstract][Full Text] [Related]
6. C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study.
Voors AA; von Haehling S; Anker SD; Hillege HL; Struck J; Hartmann O; Bergmann A; Squire I; van Veldhuisen DJ; Dickstein K;
Eur Heart J; 2009 May; 30(10):1187-94. PubMed ID: 19346228
[TBL] [Abstract][Full Text] [Related]
7. N-terminal pro-B-type natriuretic peptide in risk stratification after acute myocardial infarction in patients on long-term beta-adrenergic receptor blocker therapy.
Jonsson G; Abdelnoor M; Landaas S; Muller C; Kjeldsen SE; Os I; Westheim A
Cardiology; 2006; 106(2):102-8. PubMed ID: 16636540
[TBL] [Abstract][Full Text] [Related]
8. N-terminal probrain natriuretic peptide predicts adverse outcomes in acute-myocardial infarction even with preserved left ventricular ejection fraction.
Puri A; Narain VS; Mehrotra S; Dwivedi SK; Saran RK; Puri VK
Indian Heart J; 2006; 58(2):138-43. PubMed ID: 18989058
[TBL] [Abstract][Full Text] [Related]
9. Pro-brain natriuretic peptide plasma levels, left ventricular dimensions and ejection fraction in acute dyspnoea.
Shaikh K; Hanif B; Siddique AA; Shaikh MY; Khan MN
J Coll Physicians Surg Pak; 2012 Dec; 22(12):751-5. PubMed ID: 23217478
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of Serial N-Terminal Pro-Brain Natriuretic Peptide Testing in Patients With Acute Myocardial Infarction.
Kontos MC; Lanfear DE; Gosch K; Daugherty SL; Heidenriech P; Spertus JA
Am J Cardiol; 2017 Jul; 120(2):181-185. PubMed ID: 28599802
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998
[TBL] [Abstract][Full Text] [Related]
12. Plasma concentration of amino-terminal pro-brain natriuretic peptide in chronic heart failure: prediction of cardiovascular events and interaction with the effects of rosuvastatin: a report from CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure).
Cleland JG; McMurray JJ; Kjekshus J; Cornel JH; Dunselman P; Fonseca C; Hjalmarson A; Korewicki J; Lindberg M; Ranjith N; van Veldhuisen DJ; Waagstein F; Wedel H; Wikstrand J;
J Am Coll Cardiol; 2009 Nov; 54(20):1850-9. PubMed ID: 19892235
[TBL] [Abstract][Full Text] [Related]
13. Reductions in N-Terminal Pro-Brain Natriuretic Peptide Levels Are Associated With Lower Mortality and Heart Failure Hospitalization Rates in Patients With Heart Failure With Mid-Range and Preserved Ejection Fraction.
Savarese G; Hage C; Orsini N; Dahlström U; Perrone-Filardi P; Rosano GM; Lund LH
Circ Heart Fail; 2016 Nov; 9(11):. PubMed ID: 28029640
[TBL] [Abstract][Full Text] [Related]
14. Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus.
Wolsk E; Claggett B; Pfeffer MA; Diaz R; Dickstein K; Gerstein HC; Lawson FC; Lewis EF; Maggioni AP; McMurray JJV; Probstfield JL; Riddle MC; Solomon SD; Tardif JC; Køber L
J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28554908
[TBL] [Abstract][Full Text] [Related]
15. Serum uric acid as an independent and incremental prognostic marker in addition to N-terminal pro-B-type natriuretic peptide in patients with acute myocardial infarction.
Bae MH; Lee JH; Lee SH; Park SH; Yang DH; Park HS; Cho Y; Jun JE; Chae SC
Circ J; 2011; 75(6):1440-7. PubMed ID: 21498911
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of intensive statin therapy on N-terminal pro-BNP level in non-ST-segment elevation acute myocardial infarction patients.
Shehata M; Samir A; Dardiri M
J Interv Cardiol; 2017 Dec; 30(6):514-521. PubMed ID: 28812321
[TBL] [Abstract][Full Text] [Related]
17. B-type natriuretic peptide is a major predictor of ventricular tachyarrhythmias.
Levine YC; Rosenberg MA; Mittleman M; Samuel M; Methachittiphan N; Link M; Josephson ME; Buxton AE
Heart Rhythm; 2014 Jul; 11(7):1109-16. PubMed ID: 24837348
[TBL] [Abstract][Full Text] [Related]
18. Effect of compensated renal dysfunction on approved heart failure markers: direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP.
Luchner A; Hengstenberg C; Löwel H; Riegger GA; Schunkert H; Holmer S
Hypertension; 2005 Jul; 46(1):118-23. PubMed ID: 15939804
[TBL] [Abstract][Full Text] [Related]
19. Effect of statin treatment in patients with acute myocardial infarction and left ventricular systolic dysfunction according to the level of high-sensitivity C-reactive protein.
Jeong HC; Ahn Y; Park KH; Sim DS; Hong YJ; Kim JH; Jeong MH; Kim YJ; Chae SC; Cho MC; Chae JK; Kim CJ; Rha SW; Jang YS; Oh SK; Seong IW; Cha KS
Int Heart J; 2014; 55(2):106-12. PubMed ID: 24632965
[TBL] [Abstract][Full Text] [Related]
20. Biochemical diagnosis of impaired left ventricular ejection fraction--comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP).
Mueller T; Gegenhuber A; Poelz W; Haltmayer M
Clin Chem Lab Med; 2004 Feb; 42(2):159-63. PubMed ID: 15061354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
